REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 1 filers reported holding REDHILL BIOPHARMA LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $303,000 | -88.0% | 54,600 | -80.8% | 0.01% | -80.0% |
| Q3 2018 | $2,516,000 | -47.8% | 284,900 | -49.6% | 0.03% | -47.4% |
| Q2 2018 | $4,819,000 | +65.7% | 564,900 | 0.0% | 0.06% | +58.3% |
| Q1 2018 | $2,909,000 | +0.2% | 564,900 | 0.0% | 0.04% | -2.7% |
| Q4 2017 | $2,904,000 | -52.4% | 564,900 | 0.0% | 0.04% | -36.2% |
| Q3 2017 | $6,107,000 | +25.4% | 564,900 | 0.0% | 0.06% | +13.7% |
| Q2 2017 | $4,869,000 | -10.1% | 564,900 | 0.0% | 0.05% | -16.4% |
| Q1 2017 | $5,417,000 | -8.3% | 564,900 | 0.0% | 0.06% | -18.7% |
| Q4 2016 | $5,909,000 | -24.7% | 564,900 | 0.0% | 0.08% | -15.7% |
| Q3 2016 | $7,846,000 | +27.8% | 564,900 | 0.0% | 0.09% | +39.1% |
| Q2 2016 | $6,138,000 | -11.3% | 564,900 | 0.0% | 0.06% | -12.3% |
| Q1 2016 | $6,920,000 | -4.9% | 564,900 | 0.0% | 0.07% | +10.6% |
| Q4 2015 | $7,276,000 | -0.2% | 564,900 | 0.0% | 0.07% | -10.8% |
| Q3 2015 | $7,293,000 | -26.7% | 564,900 | 0.0% | 0.07% | +1.4% |
| Q2 2015 | $9,948,000 | -0.3% | 564,900 | -17.6% | 0.07% | -14.1% |
| Q1 2015 | $9,978,000 | +23.6% | 685,800 | +13.2% | 0.08% | +10.4% |
| Q4 2014 | $8,075,000 | +1.2% | 605,800 | 0.0% | 0.08% | -7.2% |
| Q3 2014 | $7,978,000 | -24.7% | 605,800 | 0.0% | 0.08% | -33.1% |
| Q2 2014 | $10,595,000 | +19.1% | 605,800 | -4.1% | 0.12% | +13.8% |
| Q1 2014 | $8,899,000 | – | 631,580 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |